Liver and bile duct cancer registry study
Part of Cancer, Digestive system clinical trials.
This registry collects information from people with liver cancer or bile duct cancer to learn more about the disease and its treatment. Anyone 18 or older with any stage of these cancers can join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with liver cancer (hepatocellular carcinoma) or any type of bile duct cancer (biliary tract cancer).
- You must be 18 years old or older.
- Your cancer can be at any stage and you can have had any treatment.
- You must be willing to give your permission (informed consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study for adults with biliary tract cancer that looks at existing clinical information. It may help doctors understand the disease better and improve future care, without using a new treatment in a required way.
This study tests if a liver transplant can help people with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. It is for patients whose cancer has been stable for at least 6 months after initial treatments.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This study builds a database for gallbladder cancer by collecting medical information and blood samples from patients. It helps doctors better understand the disease and improve future treatments.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study follows people with bile duct cancer or certain liver cancers to better understand their disease. You might be included if you meet the diagnosis and basic participation requirements.
Hear when a new Liver and Intrahepatic Biliary Tract Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.